Federated learning for predicting clinical outcomes in patients with COVID-19
Ittai Dayan(Harvard University), Won Young Tak(Kyungpook National University Hospital), Thomas M. Grist(University of Wisconsin–Madison), Peiying Ruan(Nvidia (United States)), Keith J. Dreyer(Political Research Associates), Jason C. Crane(University of California, San Francisco), Sira Sriswasdi(Chulalongkorn University), Pedro Mário Cruz e Silva(Nvidia (United States)), Anas Z. Abidin(University of Rochester), Gustavo Niño(Pennsylvania State University), Shuichi Kawano(Self-Defense Forces Central Hospital), Bradford J. Wood(National Institutes of Health), Jesse Tetreault(Nvidia (United States)), Chien‐Sung Tsai(Tri-Service General Hospital), Watsamon Jantarabenjakul(Chulalongkorn University), Chun‐Nan Hsu(University of California San Diego), Kristopher Kersten, Holger R. Roth(Nvidia (United States)), C. K. Lee(Tri-Service General Hospital), Varun Buch, Po‐Chuan Wang(Tunghai University), Nicola Rieke, Dufan Wu(Harvard University), Daguang Xu(Nvidia (United States)), Jiahui Guan(Chinese University of Hong Kong, Shenzhen), Marcio Aloísio Bezerra Cavalcanti Rockenbach, Griffin Lacey(Nvidia (United States)), Gustavo César de Antônio Corradi(DASA (Brazil)), Pablo F. Damasceno(University of California, San Francisco), Ahmed Harouni, Anthony Costa, Hirofumi Obinata(Self-Defense Forces Central Hospital), Amilcare Gentili(United States Department of Veterans Affairs), Aoxiao Zhong(Harvard University), Joshua Kaggie(University of Cambridge), Krishna Juluru(Ulsan College), Meena AbdelMaseeh(Lunenfeld-Tanenbaum Research Institute), Eddie Huang(Nvidia (United States)), Felipe Kitamura(Ulsan College), Marius George Linguraru(George Washington University Hospital), Soo Young Park(Kyungpook National University Hospital), Hui Ren(Harvard University), Andy Liu(National Jewish Health), Chih‐Hung Wang(National Defense University), Sheng Xu(National Institutes of Health), Masoom A. Haider(Princess Margaret Cancer Centre), Hao-Hsin Shin(Memorial Sloan Kettering Cancer Center), John W. Garrett(University of Wisconsin–Madison), Jung Gil Park(Yeungnam University College), Weichung Wang(National Taiwan University of Science and Technology)
Cited by 760
Related Papers
Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer
|JAMA|2017|3.3k
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study
|Journal of Clinical Oncology|2013|596
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma
|European Journal of Cancer|2011|573